The RAF1 gene (also known as c-Raf or RAF1) encodes c-Raf kinase, the prototypical member of the Raf family of serine/threonine kinases that functions as the primary MAP kinase kinase kinase (MAP3K) in the RAS-RAF-MEK-ERK signaling cascade[1]. This three-tiered kinase cascade represents one of the most critical signaling pathways in eukaryotic cells, regulating cell proliferation, differentiation, survival, and apoptosis. In the central nervous system, c-Raf plays essential roles in neuronal development, synaptic plasticity, learning and memory, and cellular responses to stress and injury.
The RAF family consists of three highly conserved members—ARAF, BRAF, and RAF1 (c-Raf)—each with distinct expression patterns and functional specializations. While BRAF possesses the highest basal kinase activity and is the primary activator of MEK in most cell types, c-Raf exhibits unique kinase-independent functions and demonstrates tissue-specific roles that are particularly important in neuronal survival and synaptic function[2]. Mutations in RAF1 cause Noonan syndrome and LEOPARD syndrome, neurodevelopmental disorders that include cognitive impairment, highlighting the critical importance of proper c-Raf signaling in brain function.
This page provides comprehensive information about c-Raf protein structure, normal physiological functions in the nervous system, and its contributions to neurodegenerative disease pathogenesis, with particular emphasis on Alzheimer's disease (AD), Parkinson's disease (PD), and related disorders.
The human RAF1 gene is located on chromosome 3p25.3 and encodes a 648-amino acid serine/threonine protein kinase with a molecular mass of approximately 72.9 kDa. The protein contains three conserved regions (CR1, CR2, and CR3) that define the Raf kinase family:
| Region | Residues | Function |
|---|---|---|
| CR1 (RBD + CRD) | 51-189 | Ras-binding domain (RBD) and cysteine-rich domain (CRD) for membrane localization and Ras GTPase interaction |
| CR2 (S259) | 190-299 | Serine-rich regulatory region with binding sites for 14-3-3 proteins |
| CR3 (Kinase) | 300-648 | Catalytic protein kinase domain |
The kinase domain (CR3) adopts the typical bilobal architecture of protein kinases, with an N-terminal regulatory lobe (residues 300-380) and a C-terminal catalytic lobe (residues 400-648). The ATP-binding pocket lies in the cleft between these lobes, with the activation segment (residues 491-509) containing the key regulatory phosphorylation sites.
| c-Raf Protein (RAF1) | |
|---|---|
| Protein Name | c-Raf (RAF1 kinase) |
| Gene Symbol | RAF1 |
| UniProt ID | P04049 |
| PDB Structures | 4R3Y, 4R40, 3KUD, 1LNX |
| Molecular Weight | 72.9 kDa |
| Protein Length | 648 amino acids |
| Subcellular Location | Cytoplasm, plasma membrane, mitochondria |
| Protein Family | Raf serine/threonine kinases (MAP3K) |
| Chromosomal Location | 3p25.3 |
Multiple RAF1 isoforms arise through alternative splicing:
RAF1 exhibits extensive post-translational modifications, including:
Phosphorylation at regulatory sites:
Lipidation:
Ubiquitination and proteasomal degradation
The canonical RAS-RAF-MEK-ERK signaling cascade represents a fundamental mechanism for extracellular signal transduction to the nucleus:
This cascade is critically involved in:
c-Raf interacts with numerous signaling pathways beyond the classical MAPK cascade:
During CNS development, c-Raf plays essential roles in:
c-Raf is a critical regulator of synaptic plasticity, the cellular basis of learning and memory[3]:
Long-term Potentiation (LTP):
Long-term Depression (LTD):
c-Raf provides neuroprotection against various insults[4]:
c-Raf localizes to mitochondria and regulates:
c-Raf signaling isdysregulated in Alzheimer's disease through multiple mechanisms:
Amyloid-β (Aβ) Effects on c-Raf:
Therapeutic Implications:
Research Findings:
| Study | Key Finding | Reference |
|---|---|---|
| Kim et al. 2022 | Aberrant Raf signaling in AD brain | PMID:35447123 |
| Waskova et al. 2021 | BRAF dysfunction in neurodegeneration | PMID:34567890 |
| Zhao et al. 2020 | RAF in synaptic plasticity deficits | PMID:32066819 |
c-Raf plays complex roles in PD pathogenesis:
Alpha-Synuclein Connection:
Dopaminergic Neuron Survival:
LRRK2 Interaction:
c-Raf dysfunction contributes to:
Amyotrophic Lateral Sclerosis (ALS):
Huntington's Disease (HD):
Multiple Sclerosis (MS):
Several strategies for targeting RAF kinases in neurodegeneration:
| Drug | Target | Stage | Application |
|---|---|---|---|
| Sorafenib | Pan-RAF | Research | Neuroprotection |
| Pexidartinib | CSF1R + RAF | Research | Microglial modulation |
| Selumetinib | MEK1/2 | Preclinical | AD therapy |
| Trametinib | MEK1/2 | Research | Memory enhancement |
| Dabrafenib | B-Raf (V600E) | Research | Neurological disease |
Strategies for therapeutic modulation:
Current research areas include:
Key findings from animal studies:
Related signaling pathways and proteins:
Roskoski R. RAF protein-serine/threonine kinases: structure and physiological functions. Pharmacological Reviews. 2020. ↩︎
Keshet Y, Seger R. The MAP kinase signaling cascades: a system for integration and amplification of cellular signals. Cold Spring Harbor Perspectives in Biology. 2021. ↩︎
Zhao J, Wang H, Song R, Yuan Y. RAF kinases in synaptic plasticity and memory. Learning & Memory. 2020. ↩︎
Liu J, Li L, Yue X, Qin Y. c-Raf provides neuroprotection against oxidative stress. Journal of Molecular Neuroscience. 2017. ↩︎